Doximity, Inc.
33.39USD
-0.2900 (-0.86%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on DOCS.
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 419.1M | 475.4M | 570.4M | 644.9M | 675.6M | 720.7M |
| Q1 | 90.6M | 108.5M | 126.7M | 145.9M | 156.6M | — |
| Q2 | 102.2M | 113.6M | 136.8M | 168.5M | 170.3M | — |
| Q3 | 115.3M | 135.3M | 168.6M | 185.1M | 193.4M | — |
| Q4 | 111.0M* | 118.1M* | 138.3M* | 145.4M* | — | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | .530 | .720 | 1.11 | .980 | 1.35 | 1.56 |
| Q1 | .100 | .130 | .210 | .270 | .130 | — |
| Q2 | .120 | .150 | .220 | .310 | .350 | — |
| Q3 | .160 | .240 | .370 | .310 | .418 | — |
| Q4 | .144* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .197* |
| .310* |
| .096* |
| — |
| — |
Debt level and coverage